IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 90 filers reported holding IRADIMED CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $267 | +7.7% | 6,025 | +15.9% | 0.00% | – |
| Q2 2023 | $248 | +25.3% | 5,198 | +2.8% | 0.00% | – |
| Q1 2023 | $198 | +23.0% | 5,055 | -11.2% | 0.00% | – |
| Q4 2022 | $161 | -99.9% | 5,692 | +0.2% | 0.00% | – |
| Q3 2022 | $170,000 | -12.4% | 5,680 | -0.8% | 0.00% | – |
| Q2 2022 | $194,000 | +104.2% | 5,724 | +168.6% | 0.00% | – |
| Q1 2022 | $95,000 | 0.0% | 2,131 | +3.3% | 0.00% | – |
| Q4 2021 | $95,000 | +295.8% | 2,063 | +150.4% | 0.00% | – |
| Q2 2021 | $24,000 | +71.4% | 824 | +27.0% | 0.00% | – |
| Q4 2020 | $14,000 | -17.6% | 649 | -18.9% | 0.00% | – |
| Q3 2020 | $17,000 | -59.5% | 800 | -55.9% | 0.00% | – |
| Q2 2020 | $42,000 | -4.5% | 1,815 | -13.3% | 0.00% | – |
| Q1 2020 | $44,000 | +158.8% | 2,093 | +184.4% | 0.00% | – |
| Q4 2019 | $17,000 | +88.9% | 736 | +67.3% | 0.00% | – |
| Q3 2019 | $9,000 | – | 440 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 140,752 | $3,290,000 | 3.17% |
| RK Capital | 222,914 | $5,212,000 | 1.95% |
| Nine Ten Capital Management LLC | 130,272 | $3,046,000 | 0.76% |
| Parkman Healthcare Partners LLC | 93,500 | $2,186,000 | 0.63% |
| Ranger Investment Management | 244,963 | $5,727,000 | 0.38% |
| CADENCE CAPITAL MANAGEMENT LLC | 107,043 | $2,503,000 | 0.27% |
| ALGERT GLOBAL LLC | 29,652 | $693,000 | 0.21% |
| Mondrian Investment Partners LTD | 163,939 | $3,833,000 | 0.10% |
| NAVELLIER & ASSOCIATES INC | 20,800 | $486,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 56,811 | $1,328,000 | 0.04% |